Dec
21
Pharma Consulting Plays A Key Role In Leveraging Pharmaceutical Sales
December 21, 2009 | Leave a Comment
The healthcare system represents an extremely complex dynamic and due to its size can be a primary driver of a country’s economic engine. There are many different incentives and restrictions governing the use of an individual pharmaceutical product and many different agendas along the way. Before a pharmaceutical products can be brought to the market, it faces a difficult road from the desk of a scientist to the hand of the consumer. Invariably, pharmaceutical consultants are critical to this journey, as they help all those involved to understand the situation, disseminate the information and make decisions.
A pharmaceutical company faces many challenges, quite apart from the manufacture of its products. The pharmaceutical consulting firm helps the company understand how it needs to educate the consumer. Most often, the pharmaceutical companies are at the cutting-edge of science and help to uncover solutions or possibilities previously unheard-of. If they have not paid sufficient attention to marketing, all the exploratory work may fail as the path through the regulators to the professionals may seem unclear. Those with a financial interest, especially the all important insurers, will also benefit from a good marketing approach, as they will be made aware of the positive features and benefits associated.
Before a new product may arrive on the desk of the regulators, who determine its future, the company must have marketed both its products and its history within a very competitive and busy environment. There are a lot of vested interests to take into account and some of these interests may promote older or generic medications, sometimes to the general detriment of the patient. Pharmaceutical companies have a clear incentive to trumpet the benefits of their wares in such a noisy marketplace and help to create a dynamic and forward thinking mindset.
It is unfortunate that the ultimate care of the patient is very often not the ultimate goal of certain vested interests. While healthcare reform and especially its associated finances remain a hot button issue, the pharmaceutical company must do everything in its power to ensure that its lines of communication are open. The harried physician must listen to many different interested parties before a decision can be made about the patient, including the views of other professionals, training and education, patient restrictions, formularies, best practices and traditions. If you consider that nine out of ten most frequently prescribed drugs are generics, it should be clear that far from being in a position of dominance, pharmaceutical companies must make every effort to ensure that their marketing messages are heard. In most cases, pharma consulting firms are used to this difficult environment and can certainly help to open channels and engage practices.
Pharmaceutical companies have been responsible for many of the most amazing discoveries in the world of medicine. Cures that would have been unheard-of a generation ago are now commonplace. To enable healthcare to continue to get better, much emphasis must be placed on marketing.
Alan Gillies is the Director of L2L Consulting, an elite pharmaceutical consultancy firm which specialises in Strategy Development and Implementation Excellence for prestigious multi-national organisations.